✦ LIBER ✦

Ultrasonographic markers and preoperative CA-125 to distinguish between borderline ovarian tumors and stage I ovarian cancer

✍ Scribed by Zacharakis, Dimitrios; Thomakos, Nikolaos; Biliatis, Ioannis; Rodolakis, Alexandros; Simou, Maria; Daskalakis, Georgios; Bamias, Aris; Antsaklis, Aris

Book ID: 120974312
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 246 KB
Volume: 92
Category: Article
ISSN: 0001-6349
DOI: 10.1111/aogs.12046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is CA-125 an additional marker to ultras

Is CA-125 an additional marker to ultrasonographic features for distinguishing between borderline ovarian tumors and stage I ovarian cancer?

✍ D. Zacharakis; N. Thomakos; A. Rodolakis; M. Simou; D. Haidopoulos; G. Vlachos; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Evaluation of selected ultrasonographic

Evaluation of selected ultrasonographic parameters and marker levels in the preoperative differentiation of borderline ovarian tumors and ovarian cancers

✍ Piotr Sobiczewski, Anna Dańska-Bidzińska… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 238 KB

Preoperative CA 125: An independent prog

Preoperative CA 125: An independent prognostic factor in patients with stage I epithelial ovarian cancer

✍ Fritz Nagele; Edgar Petru; Michael Medl; Christian Kainz; Anton H. Graf; Paul Se 📂 Article 📅 1995 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 651 KB

Comparison between Soluble Tumor Necrosi

Comparison between Soluble Tumor Necrosis Factor Receptors and CA125 in Peritoneal Fluids as a Marker for Epithelial Ovarian Cancer

✍ Mathias Onsrud; Ayman Shabana; Rigmor Austgulen; Kjell Nustad 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Preoperative serum tetranectin, CA125 an

Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors

✍ F.D. Begum; E. Høgdall; S.K. Kjaer; J. Blaakaer; I.J. Christensen; L. Christense 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 410 KB

517 Clinical (WHO) and serum tumor marke

517 Clinical (WHO) and serum tumor marker (CA125) response to platinum based chemotherapy after treatment with paclitaxel in patients with ovarian cancer (OVCA)

✍ J.B. Vermorken; R.V.H.P. Huijskes; K. Hoekman; C.W. Burger; R.H.M. Verheijen; M. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 148 KB